XD14

XD14
Item number Size Datasheet Manual SDS Delivery time Quantity Price
SYN-3048-M001 1 mg - -

3 - 9 business days*

108.00€
SYN-3048-M005 5 mg - -

3 - 9 business days*

185.00€
SYN-3048-M010 10 mg - -

3 - 9 business days*

308.00€
SYN-3048-M050 50 mg - -

3 - 9 business days*

1,001.00€
SYN-3048-M100 100 mg - -

3 - 9 business days*

-
 
BET bromodomain inhibitor with Kd values of 160, 170, 380, 490, 830 and 850nM for BRD4(1),... more
Product information "XD14"
BET bromodomain inhibitor with Kd values of 160, 170, 380, 490, 830 and 850nM for BRD4(1), BRD2(1), BRD3(1), BRD3(2), BRD2(2) and BRD4(2), respectively. XD14 also inhibits BRDT(1), CBP, p300 and BRDT(2) with Kd values of 1.2, 1.6, 2.6 and 3.7µM, respectively. XD14 has shown to attenuate proliferation of HL-60 leukemia cells in vitro.
Keywords: 4-Acetyl-N-[5-[(diethylamino)sulfonyl]-2-hydroxyphenyl]-3-ethyl-5-methyl-1H-pyrrole-2-carboxamide
Supplier: SYNkinase
Supplier-Nr: 3048

Properties

Application: BET bromodomain inhibitor
MW: 421.5 D
Formula: C20H27N3O5S
Purity: >95%
Format: Solid

Database Information

CAS : 1370888-71-3| Matching products
KEGG ID : K11722 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "XD14"
Write a review
or to review a product.
Viewed